Claim: There is no current evidence that peptides like BPC-157, TB-500, and Epitalin cause cancer because they have never been tested for this purpose.
Verdict: Unverified (75% confidence)
Explanation: The claim that peptides like BPC-157, TB-500, and Epitalin have never been tested for cancer causation is misleading. While comprehensive human clinical trials specifically targeting cancer causation are lacking, there is evidence of studies exploring their effects in cancer-related contexts. For instance, BPC-157 has been noted to increase angiogenesis, which could promote tumor growth [9]. Epitalon has been studied for its potential anticancer effects, including inhibiting leukemia development...